2021 financial calendar for ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF):

Silent period13 January 2021

Annual report 202010 February 2021

Annual General Meeting to be held at
ALK
Bøge Allé 1
2970 Hørsholm, Denmark

Written requests to have specific business
transacted at the AGM will be included in the
agenda if received by the company on
3 February 2021 at the latest
(may be e-mailed to investor@alk.net)


18 March 2021
4.00 p.m.

Silent period
7 April 2021

Three-month interim report (Q1) 2021
5 May 2021

Silent period
14 July 2021

Six-month interim report (Q2) 2021
11 August 2021

Silent period
14 October 2021

Nine-month interim report (Q3) 2021
11 November 2021


                                                       ALK-Abelló A/S


For further information please contact:
Investor Relations: Per Plotnikof, tel. +45 4574 7527, mobile +45 2261 2525
Media: Jeppe Ilkjær, mobile +45 3050 2014


About ALK
ALK is a global specialty pharmaceutical company focused on allergy and allergic asthma. It markets allergy immunotherapy treatments and other products and services for people with allergy and allergy doctors. Headquartered in Hørsholm, Denmark, ALK employs around 2,400 people worldwide and is listed on Nasdaq Copenhagen. Find more information at www.alk.net.


Attachment